109162-32-5

Basic information

• Product Name: Phenol, 2-methoxy-4-(1-piperidinylmethyl)-
• CAS NO: 109162-32-5
• Molecular Formula: C13H19NO2
• Molecular Weight: 221.299
• Mol File: 109162-32-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Phenol, 2-methoxy-4-(1-piperidinylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2-methoxy-4-(1-piperidinylmethyl)-(109162-32-5)
• EPA Substance Registry System: Phenol, 2-methoxy-4-(1-piperidinylmethyl)-(109162-32-5)

Safety Data

• Hazardous Substances Data: 109162-32-5(Hazardous Substances Data)

Upstream product

• 415928-53-9 2-methoxy-4-(N-morpholinyl)methylphenol 
• 498577-19-8 2-methoxy-4-(pyrrolidin-1-ylmethyl)phenol 
• 19861-69-9 4-((dimethylamino)methyl)-2-methoxyphenol 
• 110-89-4 piperidine 
• 121-33-5 vanillin 
• 115062-93-6 1-(4-hydroxy-3-methoxybenzyl)piperdin-1-ium chloride 

Downstream Products

• 125660-98-2 4-((benzyloxy)methyl)-2-methoxyphenol 
• 498577-19-8 2-methoxy-4-(pyrrolidin-1-ylmethyl)phenol 
• 115062-93-6 1-(4-hydroxy-3-methoxybenzyl)piperdin-1-ium chloride 

Relevant articles and documents

Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy

A series of novel 2-methoxy-phenyl dimethyl-carbamate derivatives were designed, synthesized and evaluated as site-activated MTDLs based on rivastigmine and curcumin. Most of them exhibited good to excellent AChE and BuChE inhibitory activities with sub-m

Synthesis and biological evaluation of a new class of multi-target heterocycle piperazine derivatives as potential antipsychotics

In this study, we designed and synthesized a novel series of multi-receptor ligands as polypharmacological antipsychotic agents by using a multi-receptor affinity strategy. Among them,3wcombines a multi-receptor mechanism with high mixed affinities for D

Compounds and methods for treatment of amyloid-B-peptide related disorders

The present invention relates to compounds, preparation and uses thereof, particularly in the pharmaceutical industry. The present invention discloses novel compounds of the following formula (I) more particularly useful for the treatment of Alzheimer's d